Weight-Loss Drugs May Lower Cancer Risk in Diabetic Patients, Study Finds

The study found that after four years, patients using GLP-1 receptor agonists showed a 7 percent lower risk of developing any of 14 obesity-related cancers.
by is licensed under
ad-image

Get latest news delivered daily!

We will send you breaking news right to your inbox

[ADD FORM IN PSYCODE "follow-us-card"]

Have a tip? Let us know!

ad-image
© 2025 structurefeeds.com, Privacy Policy